Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

zambon s.p.a. - colistimethatnatrium - pulver til opløsning til nebulisator - 1.000.000 ie

Unia Europejska - duński - EMA (European Medicines Agency)

zoetis belgium sa - inaktiverede bluetongue virus, serotype 1, stamme btv-1/alg2006/01 e1 rp, inaktiveret, bluetongue virus, serotype 8, stamme btv-8/bel2006/02 - bluetongue virus, immunologicals, immunologicals for bovidae, kvæg, inaktiveret, viral vacciner - kvæg - aktiv immunisering af kvæg fra 3 måneder for forebyggelse * af viraæmi forårsaget af bluetongue virus (btv), serotyper 1 og 8. * (cykelværdi (ct) ≥ 36 ved en valideret rt-pcr-metode, der indikerer ingen tilstedeværelse af virusgenomet).

Unia Europejska - duński - EMA (European Medicines Agency)

zoetis belgium sa - inaktiveret bluetongue virus, serotype-1 - immunologiske - får - aktiv immunisering af får fra 1. 5 måneder for forebyggelse af viraæmi forårsaget af bluetongue virus, serotyper-1. immunitetens begyndelse: 21 dage efter afslutning af den primære vaccinationsordning. immunitetens varighed: 12 måneder.

Unia Europejska - duński - EMA (European Medicines Agency)

zoetis belgium sa - inactivated bluetongue virus, serotype 1, strain btv-1/alg2006/01, inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02 - bluetongue virus, sheep, inactivated viral vaccines - får - aktiv immunisering af får fra 1. 5 måneder for at forhindre viraæmi forårsaget af bluetongue virus, serotyper 1 og 8. immunitetens begyndelse: 21 dage efter afslutning af den primære vaccinationsordning. immunitetens varighed: 12 måneder.

Unia Europejska - duński - EMA (European Medicines Agency)

zoetis belgium sa - inaktiveret bluetongue virus, serotype 8, stamme btv-8 / bel2006 / 02 - immunologiske - får - aktiv immunisering af får fra 1. 5 måneder for forebyggelse af viraæmi forårsaget af bluetongue virus, serotype 8.

Unia Europejska - duński - EMA (European Medicines Agency)

astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.

Unia Europejska - duński - EMA (European Medicines Agency)

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - immune sera og immunoglobuliner, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

Unia Europejska - duński - EMA (European Medicines Agency)

celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immune sera og immunoglobuliner, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Unia Europejska - duński - EMA (European Medicines Agency)

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

cross vetpharm group ltd. - bismuthsubnitrat, tung - intramammær suspension - 2,6 g/dosis - kvæg